Endocrine Disrupting Chemicals: Sources, Effects And Treatments

[1] A. Bergman, Jerrold, J.J. Heindel, S. Jobling, K.A. Kidd, and R.T. Zoeller, “State of the Science of Endocrine Disrupting Chemicals- An Assessment of the State of the Science of Endocrine Disruptors Prepared by a Group of Experts for the United Nations Environment Programme (UNEP) and WHO”, Geneva, Switzerland, 2012.10.1016/j.toxlet.2012.03.020Search in Google Scholar

[2] EC - European Commission. “Impact of endocrine disruptors on human health and wildlife”, Weybridge, UK, 1996.Search in Google Scholar

[3] R. Newbold, “Prenatal exposure to diethylstilbestrol (DES)”, Fertility and sterility, Vol. 89, Pp. 55-56, 2008.10.1016/j.fertnstert.2008.01.062Search in Google Scholar

[4] M. Shahidehnia, “Epigenetic Effects of Endocrine Disrupting Chemicals”, Journal of Environmental & Analytical Toxicology, 2016.10.4172/2161-0525.1000381Search in Google Scholar

[5] D.E.J. Bourguignon, L.C. Giudice, R. Hauser, G.S. Prins, A.M. Soto, R. Thomas Zoeller, and A.C. Gore, “Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement”, Endocrine Reviews, Vol. 30, No. 4, Pp. 293-342, 2009.10.1210/er.2009-0002Search in Google Scholar

[6] M.K. Skinner, M. Manikkam, and C. Guerrero-Bosagna, “Epigenetic transgenerational actions of endocrine disruptors”, Reproductive Toxicology, Vol. 31, No. 3, Pp. 337-343, 2011.10.1016/j.reprotox.2010.10.012Search in Google Scholar

[7] G.G. Kuiper, J.G. Lemmen, B. Carlsson, J.C. Corton, S.H. Safe, P.T. van der Saag, B. van der Burg, and J.A. Gustafsson, “Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor”, Endocrinology, Vol. 139, Pp. 4252–4263, 1998.Search in Google Scholar

[8] S.M. Dickerson, and A.C. Gore, “Estrogenic environmental endocrine-disrupting chemical effects on reproductive neuroendocrine function and dysfunction across the life cycle”, Rev Endocr Metab Disord., Vol. 8, Pp. 143–159, 2007.10.1007/s11154-007-9048-ySearch in Google Scholar

[9] Y. Cao, A.M. Calafat, D.R. Doerge, D.M. Umbach, J.C. Bernbaum, N.C. Twaddle, X. Ye, and W.J. Rogan, “Isoflavones in urine, saliva and blood of infants—data from a pilot study on the estrogenic activity of soy formula”, J. Expo. Sci. Environ Epidemiol., Vol. 19, Pp. 223–234, 2009.10.1038/jes.2008.44Search in Google Scholar

[10] S. Melmed, and R.H. Williams, “Williams textbook of Endocrinology”, Philadelphia, PA, Elsevier/Saunders, 2011.Search in Google Scholar

[11] M.M. Mahoney, and V. Padmanabhan, “Developmental programming: impact of fetal exposure to endocrine-disrupting chemicals on gonadotropin-releasing hormone and estrogen receptor mRNA in sheep hypothalamus”, Toxicology and Applied Pharmacology, Vol. 247, No. 2, Pp. 98-104, 2010.10.1016/j.taap.2010.05.017Search in Google Scholar

[12] H.N. Sarma, M. Manikkam, C. Herkimer, J. Dell’Orco, K.B. Welch, D.L. Foster, and V. Padmanabhan, “Fetal programming: excess prenatal testosterone reduces postnatal luteinizing hormone, but not folliclestimulating hormone responsiveness, to estradiol negative feedback in the female”, Endocrinology, Vol. 146, No. 10, Pp. 4281-4291, 2005.Search in Google Scholar

[13] A. Janesick, and B. Blumberg, “Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity”, Birth Defects Research, Part C: Embryo Today--Reviews, Vol. 93, No. 1, Pp. 34-50, 2011.10.1002/bdrc.20197Search in Google Scholar

[14] M.A. Hanson, and P.D. Gluckman, “Developmental origins of health and disease: moving from biological concepts to interventions and policy”, International Journal of Gynaecology and Obstetrics, Vol. 115, No. 1, Pp. S3-5, 2011.10.1016/S0020-7292(11)60003-9Search in Google Scholar

[15] R. Klein, “History of congenital hypothyroidism In :(Burrow GN, Dussault JH eds.)”, Neonatal Thyroid Screening, pp. 51-59. New York, Raven Press, 1980.Search in Google Scholar

[16] C. Casals-Casas, and B. Desvergne, “Endocrine disruptors: from endocrine to metabolic disruption”, Annual Review of Physiology, Vol. 73, Pp. 135-162, 2011.10.1146/annurev-physiol-012110-14220021054169Search in Google Scholar

[17] L.N. Vandenberg, T. Colborn, T.B. Hayes, J.J. Heindel, D.R. Jacobs, D.H. Lee, T. Shioda, A.M. Soto, F.S. vom Saal, W.V. Welshons, R.T. Zoeller, and J.P. Myers, “Hormones and endocrine-disrupting chemicals: Lowdose effects and nonmonotonic dose responses”, Endocrine Reviews, Vol. 33, No. 3, Pp. 378-455, 2012.10.1210/er.2011-1050336586022419778Search in Google Scholar

[18] J.W. Owens, and J.G. Chaney, “Weighing the results of differing ‘low dose’ studies of the mouse prostate by Nagel, Cagen, and Ashby: Quantification of experimental power and statistical results”, Regulatory Toxicology and Pharmacology, Vol. 43, No. 2, Pp. 194-202, 2005.10.1016/j.yrtph.2005.07.00116140446Search in Google Scholar

[19] P. Alonso-Magdalena, E. Vieira, S. Soriano, L. Menes, D. Burks, I. Quesada, and A. Nadal, “Bisphenol A Exposure during Pregnancy Disrupts Glucose Homeostasis in Mothers and Adult Male Offspring”, Environmental Health Perspectives, Vol. 118, No. 9, Pp. 1243-1250, 2010.Search in Google Scholar

[20] G.S. Prins, W.Y. Tang, J. Belmonte, and S.M. Ho, “Perinatal exposure to oestradiol and bisphenol A alters the prostate epigenome and increases susceptibility to carcinogenesis”, Basic and Clinical Pharmacology and Toxicology, Vol. 102, No. 2, Pp. 134-138, 2008.10.1111/j.1742-7843.2007.00166.x281939218226066Search in Google Scholar

[21] R. Elsby, J.L. Maggs, J. Ashby, D. Paton, J.P. Sumpter, and B.K. Park, “Assessment of the effects of metabolism on the estrogenic activity of xenoestrogens: A two stage approach coupling human liver microsomes and a yeast estrogenicity assay”, Pharmacology and Experimental Therapeutics, Vol. 296, No. 2, Pp. 329-337, 2001.Search in Google Scholar